• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Hero Background

    Tuberculosis Vaccine Treatment Companies

    ID: MRFR/Pharma/1152-HCR
    200 Pages
    Rahul Gotadki
    October 2025

    The development of a new tuberculosis (TB) vaccine has been an active area of research and investment. TB is a bacterial infection caused by Mycobacterium tuberculosis, and while the Bacille Calmette-Guérin (BCG) vaccine is currently used for TB prevention, there is ongoing research to develop more effective vaccines.

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Tuberculosis Vaccine Treatment Market Research Report - Global Forecast till 2035 Infographic
    Summary Table of Contents Segmentation Download PDF

    Top Industry Leaders in the Tuberculosis Vaccine Treatment Market

    Tuberculosis Vaccine Treatment Market

     


    Latest Tuberculosis Vaccine Treatment Companies Updates:


    GSK Following the positive Phase 3 trial results for M72/AS01E, GSK is gearing up for regulatory submissions and expects potential market launch in the coming years.


    Serum Institute of India This Indian biotech giant is developing its own TB vaccine candidate, with plans to enter Phase 3 trials soon.


    Hi-Tech Medical International This Australian company is exploring a novel DNA-based vaccine approach for TB prevention.


    List of Tuberculosis Vaccine Treatment Key companies in the market:



    •  Merck & Co., Inc.(US)

    • Sanofi Pasteur SA (France)

    • Serum Institute of India Pvt. Ltd. (India)

    • GlaxoSmithKline plc (UK)

    • IDT Biologics GmbH

    • GreenSignal Bio Pharma Limited (India)

    • Taj Pharmaceuticals Limited (India)

    • Bavarian Nordic(US)

    • Solvay(US)

    • Informa plc.(US)